Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | 0% | $ 346.32M | $ 0 |
3/31/2025 | 0% | $ 171.72M | $ 0 |
12/31/2024 | 0% | $ 49.42M | $ 0 |
9/30/2024 | 0% | $ 78.26M | $ 0 |
6/30/2024 | 0% | $ 92.18M | $ 0 |
3/31/2024 | 0% | $ 326.48M | $ 0 |
12/31/2023 | 0% | $ 169.98M | $ 0 |
9/30/2023 | 0% | $ 85.75M | $ 0 |
6/30/2023 | 0% | $ 112.84M | $ 0 |
3/31/2023 | 0% | $ 114.1M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for CYTOMX THERAPEUTICS INC is calculated as follows: (-1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 326.81M ]
(=) Debt Paydown Yield [ 0% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.29K |
---|---|
min | -11.5% |
max | 11.52% |
average | -0.08% |
median | 0% |
std | 3.82% |